I want to take a moment here for a call to action.

So, you know, our audience is probably some of the smartest,

most well-informed, courageous, and active audiences of any show ever.

And we're going to call upon them here for,

and we'll give them a little background.

So on April 6, Verpack had a meeting and they put out a notice.

This was the notice here and this was for a docket,

a request for comments.

And it says here, this meeting will be held to discuss considerations

for use of COVID-19 vaccine booster doses

and the process for COVID-19 vaccine strain selection

to address current and emerging variants.

And then Dorian Fink, he is the deputy director,

he's the clinical division of vaccines

and related products, applications.

He put together this thing called the future,

the framework for the future.

And it's talking about, again, strain composition

and use of additional boosters.

So let's look at some of the slides here.

And why is this important?

Because they're talking about uploading new strains

...